A Study to Evaluate the Long-term Safety of Inclacumab Administered to Participants With Sickle Cell Disease
Public ClinicalTrials.gov record NCT05348915. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-label Extension Study to Evaluate the Long-term Safety of Inclacumab Administered to Participants With Sickle Cell Disease Who Have Participated in an Inclacumab Clinical Trial
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is an open-label study to evaluate the safety of long-term administration of inclacumab in participants with sickle cell disease (SCD). Participants in this study will have completed a prior study of inclacumab.
Study identification
- NCT ID
- NCT05348915
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 242 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 29, 2022 (Actual)
- Primary completion
- Nov 7, 2025 (Actual)
- Completion
- Nov 7, 2025 (Actual)
- Last update posted
- Dec 17, 2025
2022 – 2025
United States locations
- U.S. sites
- 18
- U.S. states
- 10
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Strada Patient Care Center, Pediatric Hematology | Mobile | Alabama | 36604 | — |
| University of South Alabama Children's and Women's Hospital | Mobile | Alabama | 36604 | — |
| South Alabama Medical Science Foundation | Mobile | Alabama | 36606 | — |
| Arkansas Children's Hospital | Little Rock | Arkansas | 72202 | — |
| UC Irvine Medical Center | Orange | California | 92868 | — |
| UConn-Neag Comprehensive Cancer Center | Farmington | Connecticut | 06030 | — |
| University of Illinois at Chicago (UIC) Clinical Research Center | Chicago | Illinois | 60612 | — |
| University of Illinois Hospital and Health Sciences System (UI Health) | Chicago | Illinois | 60612 | — |
| Brigham And Woman's Hospital | Boston | Massachusetts | 02115 | — |
| Dana-Farber Cancer Institute IDS Pharmacy | Boston | Massachusetts | 02215 | — |
| Dana-Farber Cancer Institute | Boston | Massachusetts | 02215 | — |
| University of Michigan Hospitals - Michigan Medicine | Ann Arbor | Michigan | 48109 | — |
| Jacobi Medical Center | The Bronx | New York | 10461 | — |
| Duke University Medical Center | Durham | North Carolina | 27705 | — |
| DUMC Investigational Drug Services Pharmacy | Durham | North Carolina | 27710 | — |
| McGovern Medical School at UTHealth | Houston | Texas | 77030 | — |
| UT Health Science Center at Houston - Clinical Research Unit at Memorial Hermann Hospital | Houston | Texas | 77030 | — |
| UT Physicians Comprehensive Sickle Cell Center Houston | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 32 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05348915, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 17, 2025 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05348915 live on ClinicalTrials.gov.